Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v11-EN
Language English English
Date Updated 2017-04-13 2017-04-12
Drug Identification Number 02439603 02439603
Brand name VYVANSE VYVANSE
Common or Proper name Lisdexamfetamine Lisdexamfetamine
Company Name SHIRE PHARMA CANADA ULC SHIRE PHARMA CANADA ULC
Ingredients LISDEXAMFETAMINE DIMESYLATE LISDEXAMFETAMINE DIMESYLATE
Strength(s) 10MG 10MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size Bottles of 100 capsules Bottles of 100 capsules
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-04-04 2017-04-04
Actual start date 2017-04-04 2017-04-04
Estimated end date 2017-04-11 2017-04-11
Actual end date 2017-04-12 2017-04-12
Shortage status Resolved Actual shortage
Company comments Shire Distribution Center shortage only. Patient impact is not anticipated. Shire Distribution Center shortage only. Patient impact is not anticipated.
Health Canada comments